Hemoglobin and Iron Metabolism Practice Questions

Q: Heme is converted to bilirubin mainly in which organ?

Spleen. ### Explanation **Correct Option: C. Spleen** The degradation of heme occurs within the **Reticuloendothelial System (RES)**, also known as the Mononuclear Phagocyte System. Senescent (old) erythrocytes are primarily trapped and destroyed in the **spleen**, which acts as the "graveyard of RBCs." Inside splenic macrophages, the enzyme **Heme Oxygenase** breaks down heme into biliverdin, releasing iron and carbon monoxide. Subsequently, **Biliverdin Reductase** converts biliverdin into unconjugated bilirubin. While the RES in the liver and bone marrow also participates, the spleen is the primary anatomical site for this physiological process. **Why other options are incorrect:** * **A. Kidney:** The kidney does not metabolize heme. It is responsible for excreting water-soluble urobilin (which gives urine its yellow color) but does not produce bilirubin. * **B. Liver:** This is a common point of confusion. The liver is responsible for the **conjugation** of bilirubin (via UDP-glucuronosyltransferase) and its excretion into bile, but the initial conversion of heme to bilirubin occurs predominantly in the spleen. * **D. Bone Marrow:** While the bone marrow contains RES cells that can degrade heme (especially in cases of ineffective erythropoiesis), it is not the *main* site for the physiological turnover of aged RBCs. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting step:** Heme Oxygenase is the rate-limiting enzyme in bilirubin synthesis. * **Only source of CO:** The conversion of heme to biliverdin is the only endogenous reaction in the human body that produces **Carbon Monoxide (CO)**. * **Van den Bergh Reaction:** Unconjugated bilirubin (produced in the spleen) gives an **indirect** reaction, while conjugated bilirubin (produced in the liver) gives a **direct** reaction. * **Transport:** Unconjugated bilirubin is water-insoluble and must be transported to the liver bound to **albumin**.

Q: What is the normal total iron binding capacity?

300-400 mg/dL. **Explanation:** **Total Iron Binding Capacity (TIBC)** is a clinical measure of the maximum amount of iron that can be bound by plasma proteins, primarily **Transferrin**. Since each transferrin molecule can bind two atoms of ferric iron ($Fe^{3+}$), TIBC serves as an indirect surrogate marker for the concentration of transferrin in the blood. 1. **Why the correct answer is right:** The physiological range for TIBC in a healthy adult is typically **300–400 mg/dL** (some texts cite 250–450 µg/dL, but mg/dL is the standard unit used in this context). Under normal conditions, only about one-third of the available iron-binding sites on transferrin are occupied by iron (Transferrin Saturation ≈ 33%). 2. **Why the incorrect options are wrong:** * **Options A, B, and C (0.5–2.5 mg/Litre):** These values are extremely low and do not correlate with any standard iron study parameters. For comparison, normal serum iron levels are roughly 50–150 µg/dL, which is significantly higher than these options when converted. These distractors use incorrect units and magnitudes. 3. **Clinical Pearls for NEET-PG:** * **Iron Deficiency Anemia (IDA):** TIBC **increases** as the body attempts to compensate for low iron by producing more transferrin. * **Anemia of Chronic Disease (ACD):** TIBC **decreases** or remains normal because the body sequesters iron and reduces transferrin production. * **Hemochromatosis:** TIBC **decreases** as transferrin becomes highly saturated with iron. * **Formula:** $Transferrin\ Saturation\ (\%) = (Serum\ Iron / TIBC) \times 100$.

Q: Which vitamin is required for the rate-limiting step of heme synthesis?

Vitamin B6. ### Explanation **Correct Option: D (Vitamin B6)** The rate-limiting step of heme synthesis is the condensation of **Succinyl CoA** and **Glycine** to form **$\delta$-Aminolevulinic acid (ALA)**. This reaction is catalyzed by the enzyme **ALA Synthase (ALAS)**, which is located in the mitochondria. **Pyridoxal Phosphate (PLP)**, the active form of **Vitamin B6**, serves as an essential co-factor for ALA Synthase. It facilitates the decarboxylation of glycine, allowing the reaction to proceed. Without Vitamin B6, heme production is impaired, leading to **Sideroblastic Anemia**, where iron accumulates in the mitochondria of erythroid precursors (forming "ringed sideroblasts") because it cannot be incorporated into heme. --- ### Analysis of Incorrect Options * **A. Vitamin B1 (Thiamine):** Acts as a co-factor for oxidative decarboxylation reactions (e.g., Pyruvate Dehydrogenase, $\alpha$-Ketoglutarate Dehydrogenase) and Transketolase. It is not involved in heme synthesis. * **B. Vitamin B2 (Riboflavin):** Precursor for FMN and FAD, which are involved in redox reactions (e.g., Succinate Dehydrogenase). * **C. Vitamin B3 (Niacin):** Precursor for NAD and NADP, primarily involved in electron transport and various metabolic pathways, but not the ALAS reaction. --- ### High-Yield Clinical Pearls for NEET-PG * **Rate-limiting enzyme:** ALA Synthase (ALAS-1 in liver; ALAS-2 in erythroid tissue). * **Inhibitors:** Hemin and Glucose inhibit ALAS-1 (relevant in managing Porphyrias). * **Drug-induced Anemia:** **Isoniazid (INH)**, used in TB treatment, inhibits Pyridoxine kinase. This leads to Vitamin B6 deficiency and subsequent Sideroblastic Anemia. * **Lead Poisoning:** Inhibits **ALA Dehydratase** and **Ferrochelatase**, but *not* the rate-limiting ALA Synthase.

Q: In blood, bilirubin is bound to which of the following?

Protein. **Explanation:** **1. Why the correct answer is right:** Bilirubin is the end product of heme catabolism. It is highly lipophilic and virtually insoluble in water. To be transported from the reticuloendothelial system (where it is formed) to the liver (where it is conjugated), it must be bound to a carrier. In the blood, **Unconjugated Bilirubin (UCB)** binds non-covalently to **Albumin**, which is the most abundant plasma protein. This binding prevents the toxic, free bilirubin from diffusing into tissues like the brain. Once it reaches the hepatocytes, it is dissociated from albumin and taken up by the liver. **2. Why the incorrect options are wrong:** * **Steroid:** Steroids are lipid-based signaling molecules (like cortisol or estrogen). While they often require carrier proteins themselves (e.g., SHBG), they do not serve as transport vehicles for other metabolites like bilirubin. * **Vitamin:** Vitamins are organic micronutrients required for metabolism. They do not have the structural capacity or concentration to act as transport carriers for metabolic waste products. * **Carbohydrate:** While bilirubin is eventually conjugated with a carbohydrate derivative (**Glucuronic acid**) inside the liver to become water-soluble, this occurs for *excretion*, not for *transport* in the blood. **3. NEET-PG High-Yield Clinical Pearls:** * **Albumin Binding Capacity:** One molecule of albumin has one high-affinity site for bilirubin. If this site is saturated or if albumin levels are low (hypoalbuminemia), free bilirubin can cross the blood-brain barrier, leading to **Kernicterus** (especially in neonates). * **Drug Interactions:** Certain drugs like **Sulfonamides** and **Salicylates** can displace bilirubin from albumin, increasing the risk of neurotoxicity. * **Van den Bergh Reaction:** Unconjugated bilirubin (bound to albumin) gives an **indirect** reaction, while conjugated bilirubin gives a **direct** reaction.

Q: What is the end product of porphyrin metabolism?

Bilirubin. ### Explanation **Correct Answer: C. Bilirubin** **The Concept:** Porphyrin metabolism is primarily concerned with the synthesis and degradation of **Heme**. In humans, the catabolism of heme (a ferroprotoporphyrin) occurs predominantly in the Reticuloendothelial System (spleen, liver, and bone marrow). 1. The enzyme **Heme Oxygenase** breaks down the porphyrin ring, releasing iron and carbon monoxide, resulting in the formation of **Biliverdin** (a green pigment). 2. **Biliverdin Reductase** then reduces biliverdin into **Bilirubin** (a yellow pigment). Bilirubin is the final metabolic waste product of the porphyrin ring that must be conjugated in the liver and excreted via bile. **Analysis of Incorrect Options:** * **A. Albumin:** This is a transport protein, not a metabolic end product. Albumin plays a crucial role in porphyrin metabolism by transporting unconjugated bilirubin (which is water-insoluble) from the peripheral tissues to the liver. * **B. CO2 & NH2:** While many organic molecules are broken down into carbon dioxide and nitrogenous waste (urea), the porphyrin ring is not fully oxidized to these components in humans. Instead, it is excreted as intact tetrapyrrole derivatives (bilirubin). **High-Yield Clinical Pearls for NEET-PG:** * **Rate-Limiting Step:** The rate-limiting enzyme of heme *synthesis* is **ALA Synthase**, while the rate-limiting step of heme *degradation* is **Heme Oxygenase**. * **Carbon Monoxide (CO):** Heme degradation is the only endogenous source of CO in the human body. * **Excretion:** Bilirubin is converted to **Urobilinogen** by intestinal bacteria. A portion is excreted in feces as **Stercobilin** (giving stool its brown color) and a small amount in urine as **Urobilin**. * **Jaundice:** Any defect in the clearance of this end product (bilirubin) leads to hyperbilirubinemia, clinically manifesting as jaundice.

Q: The affinity of hemoglobin for O2 is increased by:

Decreases in 2,3-bisphosphoglycerate (BPG). **Explanation:** The affinity of hemoglobin (Hb) for oxygen is determined by the equilibrium between two conformational states: the **T (Tense) state**, which has low affinity for $O_2$, and the **R (Relaxed) state**, which has high affinity. **Why Option D is Correct:** 2,3-Bisphosphoglycerate (2,3-BPG) is a negative allosteric effector that binds to the central cavity of the deoxyhemoglobin (T-state) and stabilizes it through ionic bonds with the beta chains. By stabilizing the T-state, 2,3-BPG promotes oxygen unloading. Therefore, a **decrease in 2,3-BPG** shifts the equilibrium toward the **R-state**, thereby **increasing hemoglobin’s affinity for oxygen** (shifting the oxygen dissociation curve to the left). **Analysis of Incorrect Options:** * **A & B:** The formation of **salt bridges** and **cross-linking** of beta chains (as seen with 2,3-BPG binding) stabilizes the **T-state**. This reduces oxygen affinity to facilitate unloading at the tissue level. * **C: Lowering the pH** (increased $[H^+]$) leads to the **Bohr Effect**. Protons protonate histidine residues in Hb, forming salt bridges that stabilize the T-state, thus decreasing oxygen affinity and shifting the curve to the right. **NEET-PG High-Yield Pearls:** * **Left Shift (Increased Affinity):** $\downarrow$ 2,3-BPG, $\downarrow$ $[H^+]$ (Alkalosis), $\downarrow$ $pCO_2$, $\downarrow$ Temperature, and HbF (Fetal hemoglobin). * **Right Shift (Decreased Affinity):** $\uparrow$ 2,3-BPG (seen in high altitudes/anemia), $\uparrow$ $[H^+]$ (Acidosis), $\uparrow$ $pCO_2$, $\uparrow$ Temperature (Exercise). * **HbF Factor:** Fetal hemoglobin has a higher affinity for $O_2$ because its gamma chains have fewer positive charges, leading to **decreased binding of 2,3-BPG**.

Question 1

Heme is converted to bilirubin mainly in which organ?

Accepted Answer

Spleen

Answer

Kidney

Answer

Liver

Answer

Bone marrow

Question 2

What is the normal total iron binding capacity?

Accepted Answer

300-400 mg/dL

Answer

0.5-1 mg/Litre

Answer

1.5-2.5 mg/Litre

Answer

1.0-1.5 mg/Litre

Question 3

Which vitamin is required for the rate-limiting step of heme synthesis?

Accepted Answer

Vitamin B6

Answer

Vitamin B1

Answer

Vitamin B2

Answer

Vitamin B3

Question 4

In blood, bilirubin is bound to which of the following?

Accepted Answer

Protein

Answer

Steroid

Answer

Vitamin

Answer

Carbohydrate

Question 5

What is false regarding iron absorption?

Accepted Answer

It primarily occurs in the duodenum.

Answer

Approximately 10% of dietary iron is absorbed.

Answer

Ascorbic acid enhances iron absorption.

Answer

Oral iron administration can increase the incidence of breath-holding spells.

Question 6

All the statements about lactoferrin are true, EXCEPT:

Accepted Answer

It transports iron for erythropoiesis

Answer

It has great affinity for iron

Answer

It is present in exocrine secretions of the body

Answer

It is present in secondary granules of neutrophils

Question 7

What is the end product of porphyrin metabolism?

Accepted Answer

Bilirubin

Answer

Albumin

Answer

CO2 & NH2

Answer

None

Question 8

The affinity of hemoglobin for O2 is increased by:

Accepted Answer

Decreases in 2,3-bisphosphoglycerate (BPG)

Answer

The formation of salt bridges in hemoglobin

Answer

The cross-linking of the beta chains of hemoglobin

Answer

Lowering the pH

Question 9

Which of the following statements is NOT true regarding iron metabolism?

Accepted Answer

Iron absorption primarily occurs in the duodenum.

Answer

Ascorbic acid promotes iron absorption.

Answer

Phytates inhibit iron absorption.

Answer

Most absorbed iron is incorporated into hemoglobin within red blood cells.

Question 10

Hemoglobin synthesis starts with which amino acid?

Accepted Answer

Histidine

Answer

Glycine

Answer

Iron

Answer

Folic acid

Hemoglobin and Iron Metabolism — MCQs

Hemoglobin and Iron Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?